A detailed history of Daiwa Securities Group Inc. transactions in Grifols Sa stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 398 shares of GRFS stock, worth $3,462. This represents 0.0% of its overall portfolio holdings.

Number of Shares
398
Previous 398 -0.0%
Holding current value
$3,462
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

BUY
$14.07 - $17.3 $2,448 - $3,010
174 Added 77.68%
398 $6,000
Q4 2020

Feb 04, 2021

SELL
$16.86 - $19.67 $8,210 - $9,579
-487 Reduced 68.5%
224 $4,000
Q4 2019

Jan 31, 2020

SELL
$19.57 - $23.52 $1,839 - $2,210
-94 Reduced 11.68%
711 $17,000
Q3 2019

Nov 04, 2019

SELL
$19.85 - $22.76 $1,369 - $1,570
-69 Reduced 7.89%
805 $16,000
Q1 2019

Apr 26, 2019

BUY
$18.01 - $20.11 $1,386 - $1,548
77 Added 9.66%
874 $18,000
Q1 2018

May 02, 2018

BUY
$20.31 - $24.95 $16,187 - $19,885
797 New
797 $17,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.91B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.